COVID-19 update, June 2: 4 new deaths in India, active toll nears 4,000 — latest updates
COVID-19 news, June 2 updates: As of 8 am today, India's active COVID-19 cases now stand at 3,961, according to data from the Ministry of Health and Family Welfare (MoH&FW) on June 2, 2025.
The daily bulletin also noted that 203 new cases were added to the official tally on June 1, taking the total near 4,000. Further, overall, since January 2025, the death toll due to COVID-19 is at 32, with five new deaths reported on June 1 (Sunday), it added.
Delhi, Tamil Nadu, Maharashtra, and Kerala each reported one COVID-19 death since Sunday.
Delhi reported 47 more COVID-19 cases, increasing the total active cases in the national capital to 483.
In Kerala, active COVID-19 cases rose to 1,435, with 35 new cases reported since Sunday.
In Maharashtra, 21 new COVID-19 cases were reported, taking the active case count to 506.
In West Bengal, 44 new COVID-19 cases were reported, increasing the state's active cases to 331.
On Friday, Union Minister of State for Health and AYUSH (Independent Charge), Prataprao Jadhav, assured that the Centre is fully prepared to handle any situation that may arise.
"Both our Central Health Department and the AYUSH Ministry are fully alert and closely monitoring the situation across all states. We have spoken with the respective Health and AYUSH Secretaries, as well as other concerned ministers," Jadhav had told ANI.
He added that the infrastructure developed during the earlier Covid-19 waves has been reviewed and that preparations are underway to deal with any eventuality.
"We've reviewed the infrastructure built during the earlier Covid waves, such as oxygen plants and ICU beds, and have already begun preparations. Our health systems are well-equipped and ready to handle any situation that may arise in response to Covid," he had said.
Meanwhile, given the current COVID-19 situation in the state, the Karnataka Health Department had issued a circular asking government and private schools to take precautions in the interest of school children's health.
The instructions are as follows: If schoolchildren develop fever, cough, cold, and other symptoms, do not send them to school. Follow appropriate treatment and care measures as advised by the doctor.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
37 minutes ago
- Time of India
Rise in COVID-19 Cases: 7 essential medical gadgets for home use
Covid cases India India is witnessing a resurgence of COVID-19 cases , with active infections now exceeding 1,000. This means, it becomes all the more essential for you to have regular health checkups and keep certain essential medical gadgets handy at home to monitor vital signs . Collecting personal health data can aid in quicker diagnosis and treatment. Several low-cost devices are available to track vitals like blood pressure, blood oxygen levels, respiration rate and pulse rate. Daily tracking can provide insights into personal health trends and help doctors detect irregularities early. Stay ready with these 7 essential medical gadgets as COVID cases rise Before you buy: Doctor's consultation recommended Before listing them, it is highly recommended to consult a doctor for advice on selecting suitable medical gadgets for personal use. All treatment, medication, and symptom tracking should be discussed with a medical professional. It is also important to note that this information is for general awareness of available devices and does not recommend specific brands or provide medical advice. Always consult your doctor or a medical professional regarding correct usage, accuracy and potential interference with other medical devices like pacemakers. Here are some essential medical gadgets to consider amid rise in Covid cases Contactless IR Thermometer: This device is crucial for quickly checking body temperature without physical contact. Consult a medical professional for model recommendations. Automatic Electronic Blood Pressure Monitor : An essential gadget for monitoring blood pressure and, ideally, pulse rate. Seek medical advice for suitable device recommendations. Fingertip Pulse Oximeter : A small, affordable device that measures blood oxygen saturation and pulse rate by simply inserting an index finger. Glucometer: Used to measure blood glucose levels. Portable Personal ECG Monitor: These devices, often with smartphone companion apps, allow for daily ECG recordings, providing vital information for doctors to detect heart irregularities early. Medical Alert System: Particularly useful for elders, these systems allow users to call for help with the press of a button during an emergency, offering a simpler alternative to finding and dialing a phone. Pain Relief Devices: Various devices like hot pads, massagers, or nerve stimulators can offer at-home pain relief. Consult your doctor to select the appropriate device for your needs. AI Masterclass for Students. Upskill Young Ones Today!– Join Now
Hans India
an hour ago
- Hans India
Ayush Nivesh Saarthi portal signals India's readiness in holistic healthcare: Piyush Goyal
New Delhi: The newly launched Ayush Nivesh Saarthi portal is rooted in tradition and signals India's readiness for holistic healthcare, Commerce and Industry Minister Piyush Goyal has said. Developed by the Ministry of Ayush in collaboration with Invest India, Ayush Nivesh Saarthi is a dedicated, investor-centric digital platform. It brings together policy frameworks, incentive structures, investment-ready projects, and real-time facilitation under one unified interface. It is designed to support both domestic and global investors, the platform is a strategic tool that strengthens India's standing as a global investment destination for traditional systems of medicine. The Ayush Nivesh Saarthi portal was launched on May 29 during the Ayush stakeholder/industry interaction meeting held at Vanijya Bhawan, New Delhi. The historic move positions India as the global epicentre for traditional medicine and wellness. 'With 100 per cent FDI permitted in the Ayush sector through the automatic route, the launch of Ayush Nivesh Saarthi is a signal to the world that India is open for investment, collaboration, and innovation in holistic healthcare,' said Piyush Goyal, during the launch. 'India's Ayush ecosystem is rooted in deep tradition but is powered by modern vision. Through this portal, we are not only connecting investors with opportunities but with India's ancient legacy of wellness,' he added. The Ayush industry has emerged as one of the fastest-growing sectors in the country, recording an annual growth of 17 per cent between 2014 and 2020. With rising global consumer interest in natural, preventive, and wellness-based healthcare, Ayush is at the forefront of a new wave in global health and lifestyle transformation. 'Ayush Nivesh Saarthi is more than a digital platform -- it is an enabler of transformation. It brings together the government's proactive policies, India's natural wealth of over 8,000 medicinal plant species, and a globally trusted wellness tradition,' said Prataprao Jadhav, Union Minister of State (Independent Charge) for Ayush. 'This portal will empower investors with real-time data, transparent policy guidance, and access to a vibrant, expanding market. Ayush is no longer just India's heritage -- it's now a global opportunity,' Jadhav added. The Ayush sector's relevance is also strongly reflected in its contributions to medical value travel (MVT) and the global wellness economy. Ranked among the top five health services in India, Ayush is a key driver of the country's $13 billion MVT sector globally. The new investor facilitation portal is expected to serve as a vital catalyst in attracting foreign direct investment, empowering entrepreneurs, and showcasing India's leadership in traditional medicine and wellness to the world. Ayush Nivesh Saarthi, Holistic Healthcare, Piyush Goyal, Traditional Medicine, Investment Platform, India Ayush Sector
NDTV
an hour ago
- NDTV
WHO Is Finalising A New Treaty To Prep For The Next Pandemic, But US Isn't Signing
On March 20, 2025, members of the World Health Organization adopted the world's first pandemic agreement, following three years of 'intensive negotiations launched by governments in response to the devastating impacts of the COVID-19 pandemic.' The U.S., however, did not participate, in part because of its intention to withdraw from the WHO. Global health experts are hailing the agreement as a historic moment. What does the agreement mean for the world, and how can it make everyone safer and more prepared for the next pandemic? The Conversation asked Nicole Hassoun, a professor at Binghamton University and executive director of Global Health Impact, to explain the pandemic accord, its prospects for advancing global health, and the significance of the U.S.'s absence from it. What will the pandemic agreement do? The accord will bolster pandemic preparation within individual countries and around the world. Countries signing onto the agreement are committing to improve their disease surveillance and grow their heath care workforces, strengthen their regulatory systems and invest in research and development. It encourages countries to strengthen their health regulations and infrastructure, improve communication with the public about pandemics and increase funding for preparation and response efforts. It also includes new mechanisms for producing and distributing vaccines and other essential countermeasures. Finally, it encourages countries to coordinate their responses and share information about infectious diseases and intellectual property so that vaccines and other essential countermeasures can be made available more quickly. The agreement will take effect once enough countries ratify it, which may take several years. Why isn't the US involved? The Biden administration was broadly supportive of a pandemic agreement and was an active participant in negotiations. Prior to Donald Trump's reelection, however, Republican governors had signed a letter opposing the treaty, echoing a conservative think tank's concerns about U.S. sovereignty. The U.S. withdrew from negotiations when President Trump signed an executive order to withdraw from the WHO on the day he was inaugurated for his second term. Why could the lack of US involvement be beneficial for the world? The lack of U.S. involvement likely resulted in a much more equitable treaty, and it is not clear that countries could have reached an agreement had the U.S. continued to object to key provisions. It was only once the U.S. withdrew from the negotiations that an agreement was reached. The U.S. and several other wealthy countries were concerned with protecting their pharmaceutical industry's profits and resisted efforts aimed at convincing pharmaceutical companies to share the knowledge, data and intellectual property needed for producing new vaccines and other essential countermeasures. Other negotiators sought greater access to vaccines and other treatments during a pandemic for poorer countries, which often rely on patented technologies from global pharmaceutical companies. While most people in wealthy countries had access to COVID-19 vaccines as early as 2021, many people in developing countries had to wait years for vaccines. How could the agreement broaden access for treatments? One of the contentious issues in the pandemic agreement has to do with how many vaccines manufacturers in each country must share in exchange for access to genetic sequences to emerging infectious diseases. Countries are still negotiating a system for sharing the genetic information on pathogens in return for access to vaccines themselves. It is important that researchers can get these sequences to make vaccines. And, of course, people need access to the vaccines once they are developed. Still, there are many more promising aspects of the agreement for which no further negotiations are necessary. For instance, the agreement will increase global vaccine supply by increasing manufacturing around the world. The agreement also specifies that countries and the WHO should work together to create a mechanism for fairly sharing the intellectual property, data and knowledge needed to produce vaccines and other essential health products. If financing for new innovation requires equitable access to the new technologies that are developed, many people in poor countries may get access to vaccines much more quickly in the next pandemic. The agreement also encourages individual countries to offer sufficient incentives for pharmaceutical companies to extend access to developing countries. If countries implement these changes, that will benefit people in rich countries as well as poor ones. A more equitable distribution of vaccines can contain the spread of disease, saving millions of lives. What more should be done, and does the US have a role to play? In my view, the best way to protect public health moving forward is for countries to sign on to the agreement and devote more resources to global health initiatives. This is particularly important given declining investment and participation in the WHO and the contraction of other international health initiatives, such as USAID. Without international coordination, it will become harder to catch and address problems early enough to prevent epidemics from becoming pandemics. It will also be imperative for member countries to provide funding to support the agreement's goals and secure the innovation and access to new technologies. This requires building the basic health infrastructure to ensure shots can get into people's arms.
